España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
BlackRock Innovation
BTX
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$7.66
-0.20
-2.54%
At close: -
$7.64
-0.02
-0.26%
After Hours: 4:40 PM EDT
Get Report
Comment
BlackRock Innovation (BTX) Forecast
News
Earnings
BlackRock Innovation (BTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for BlackRock Innovation (NYSE:BTX) Stock
BlackRock Innovation Stock (NYSE: BTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, October 12, 2022
Maxim Group Downgrades Brooklyn to Hold
Benzinga Newsdesk
Tuesday, October 11, 2022
Brooklyn ImmunoTherapeutics Announces 1-For-2...
Benzinga Newsdesk
Brooklyn ImmunoTherapeutics Announces Name Ch...
Benzinga Newsdesk
Monday, September 26, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Thursday, September 22, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Thursday, September 08, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, September 07, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Friday, September 02, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, September 01, 2022
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Friday, August 26, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Friday, August 19, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Tuesday, August 16, 2022
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Friday, August 12, 2022
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
Lisa Levin
Thursday, August 11, 2022
Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Wednesday, July 27, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, July 26, 2022
Recap Of Tuesday's Biotech Catalysts - End of The Day Summary
Ragothaman Srinivasan
Brooklyn ImmunoTherapeutics Shares Tick lower After Data From Head and Neck Cancer Study
Vandana Singh
Brooklyn ImmunoTherapeutics Announces Results...
Benzinga Newsdesk
Wednesday, July 20, 2022
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, July 18, 2022
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Monday, July 11, 2022
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, July 01, 2022
Brooklyn Immunotherapeutics Announces Co. Rec...
Benzinga Newsdesk
Monday, June 13, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Tuesday, June 07, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Friday, June 03, 2022
18 Stocks Moving in Friday's Pre-Market Session
Lisa Levin
Tuesday, May 31, 2022
Brooklyn ImmunoTherapeutics Appoints Matt Angel As Interim CEO And President, Appoints Andrew Jackson CFO
Bill Haddad
Friday, May 27, 2022
Brooklyn ImmunoTherapeutics Announces Receipt...
Benzinga Newsdesk
Wednesday, May 25, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, May 24, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Wednesday, May 11, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Friday, May 06, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Wednesday, May 04, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Friday, April 29, 2022
Brooklyn ImmunoTherapeutics S-3 Shows Registr...
Benzinga Newsdesk
Thursday, April 28, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, April 26, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, April 25, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Thursday, April 21, 2022
Brooklyn ImmunoTherapeutics Announces Establi...
Benzinga Newsdesk
Tuesday, April 19, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, April 18, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Tuesday, March 15, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, March 14, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Tuesday, March 08, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, March 07, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Brooklyn ImmunoTherapeutics Reports $12M Priv...
Benzinga Newsdesk
Tuesday, February 22, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, February 14, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, February 04, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, February 03, 2022
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Thursday, January 13, 2022
Brooklyn ImmunoTherapeutics Announces 18 New Patents Were Issued And 17 Were Filed In 2021
Bill Haddad
Wednesday, January 05, 2022
Brooklyn Immunotherapeutics Said on January 3, 2022, Co Completed Reduction in Force Comprising Eight Employees, 53% of Workforce; Co Estimates It Will Incur About $0.5M for Severance and Termination-related Costs
Charles Gross
Show More
